The FDA published a 68-page review of BPC-157, and they found one clinical trial across the whole orthopedic literature: 17 patients, who received BPC-157 mixed with a second peptide
Furthermore, IM administration of hydroxocobalamin is also the preferred treatment for pediatric patients with intrinsic cobalamin metabolic diseases
Both peptides support healing and recovery, but BPC-157 is more focused on gut health and tendon repair, while TB 500 is better for muscle recovery, flexibility, and reducing inflammation
Rotator Cuff Tear A 45-year-old male with a partial rotator cuff tear avoided surgery and experienced full resolution of pain and restoration of mobility within 8 weeks using the high-dose protocol (1mg daily), combined with physical therapy and zone 2 cardio
The statements made on this website have not been evaluated by the U.S
This therapy does not cause any harmful effects